Etrolizumab Completed Phase 1 Trials for Healthy Volunteers Health Services Research

IndicationsStatusPurposePhase
CompletedHealth Services Research1
clinicaltrials.gov IdentifierTitleDrugs
NCT02996019A Study to Compare Pharmacokinetics (PK) of Etrolizumab Administered Subcutaneously by a Prefilled Syringe With Needle Safety Device (PFS-NSD) or an Auto-injector (AI)